Is surgery necessary for locally advanced cancer in authoritative journals? Fudan Cancer Experts Establish a Specialized Scoring System Professor | System | Scoring

Release time:Apr 15, 2024 04:12 AM

Thyroid cancer is one of the most common malignant tumors in China, and many people believe it is a type of lazy cancer with a good prognosis. At present, the overall five-year survival rate of thyroid cancer in China is 84.3%. The poor prognosis of advanced patients is the main factor affecting the overall survival rate, and improving the efficacy of advanced patients is crucial. Should surgery be performed on locally advanced patients? Not long ago, Professor Wang Yu, Director of Head and Neck Surgery at Fudan University Affiliated Cancer Hospital, and Professor Gu Yajia, Director of Radiology Diagnosis Department of the hospital, jointly released a study titled "Application of CT based scoring system to evaluate the resectability of locally advanced thyroid cancer". A specialized scoring system was established to provide scientific basis for the assessment of resectability in locally advanced patients, replacing the previous situation where resectability assessment relied on subjective judgment by doctors. The results are published online in the international authoritative academic journal "European Radiology", filling the research gap in related fields.

Expert explanation: Locally advanced thyroid cancer is a type of advanced thyroid cancer that can exist in various pathological types of thyroid cancer. Local advanced stage mainly refers to the invasive state of the tumor, which invades important organs or tissues in the neck. These patients can be life-threatening due to airway obstruction or massive bleeding, which is currently a clinical treatment challenge.

For a long time, surgery has been the main treatment for thyroid cancer, and for locally advanced thyroid cancer patients, surgery is also the primary choice. However, some locally advanced patients are difficult to completely remove through surgery and require neoadjuvant treatment before considering the possibility of surgery. How to accurately evaluate the resectability of patients? In the past, it was almost entirely based on the clinical experience of doctors.

The joint team aims to establish a specialized surgical resectability scoring system for locally advanced patients and conduct large-scale research. The study is based on a multicenter queue and evaluates the extent of tumor invasion in other parts of CT images. A 12 point and 14 point evaluation system is established, and the 12 point evaluation system is optimized into the final scoring system. Comparative analysis of clinical data from different centers shows that the scoring system is effective: the overall AUC for predicting tumor resectability is 0.882. Among them, the AUC of newly treated patients and postoperative relapsed patients were 0.826 and 0.976, respectively, both of which had good predictive power. Further data suggests that the overall accuracy of the score ranges from 78.9% to 89.4%, with an AUC of 0.875.

According to the scoring results, locally advanced patients can be divided into three groups. The overall R0/1 resection rate of patients with 1-4 points is 83.33%, with a high probability of resection, mainly through direct surgical resection; The overall R0/1 resection rate of patients with a score of 9-12 is 6.45%, with a high probability of tumor residue, and systematic treatment is the main approach; The overall R0/1 resection rate of patients with a score of 5-8 is 62.5%, which is in a critical resectable state. Wang Yu said, "The evaluation system provides objective reference standards for the resectability of locally advanced patients, helping clinical doctors optimize treatment decisions and achieve better survival benefits."

Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer
Why is "Cancer King" immunotherapy ineffective? Fudan Cancer Hospital Reveals New Mechanisms of Immunosuppressive Environment for pancreatic cancer CRIP1 | Tumor | pancreatic cancer

Immunotherapy has been proven to achieve significant therapeutic effects in various solid tumors. However, for pancreatic cancer, known as the "king of cancer", immunotherapy has been ineffective. On August 4, Professor Yu Xianjun, Dean of the Cancer Hospital Affiliated to Fudan University, and Shi Si, Associate Professor of Pancreatic Surgery released a research achievement, which first found the key role of cysteine rich protein 1 in shaping the immunosuppressive microenvironment of pancreatic cancer, filled the gap in the research field of immunosuppressive microenvironment of pancreatic cancer, and provided a theoretical basis for precise immunotherapy of pancreatic cancer patients. Ductal adenocarcinoma of the pancreas is the main type of pancreatic cancer, accounting for about 90% of all pancreatic cancer. Due to its high malignancy and poor treatment effectiveness, pancreatic ductal adenocarcinoma has always been one of the most malignant tumors. In recent years, the level of surgical techniques and comprehensive treatment has been achieved

A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare
A 14-year-old girl suffers from a rare eye disease and receives support from a public welfare fund. Symptoms of "I haven't looked in the mirror for a long time" | Patient | Public welfare

A 14-year-old girl has been experiencing symptoms such as protruding pupils, incomplete eye closure, corneal injury, restricted eye movement, and overall fatigue for several years. The physical discomfort and facial abnormalities caused by eye diseases have made her increasingly reticent, and her temperament is vastly different from before. At the Ophthalmology Department of the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the pupil has been diagnosed with a rare thyroid ophthalmopathy combined with myasthenia gravis, which requires prompt treatment. However, considering the young age of the pupil, conventional hormone and radiation therapy cannot be used. Therefore, Zhou Huifang, Deputy Director of Ophthalmology and thyroid ophthalmology expert, has developed a targeted drug combined with surgical treatment plan for it, and targeted drug treatment will be performed first. Three months ago, I was hospitalized for one week with mydriasis and received intravenous targeted drug treatment. Afterwards, I went home for observation and followed up on time

The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease
The municipal eye disease prevention and treatment center launched the dry eye diagnosis and treatment studio, and the incidence rate of dry eye in China is about 21% to 30% of the meibomian gland | dry eye | eye disease

According to the Statistics of Chinese Dry Eye Expert Consensus, the incidence rate of dry eye in China is about 21%~30%, and it is estimated that there are at least 300 million patients nationwide. The Dry Eye Diagnosis and Treatment Studio of Shanghai Eye Disease Prevention and Treatment Center was officially launched today. In the future, the studio will continuously improve the dry eye diagnosis and treatment standards, and form standardized diagnosis and treatment concepts and service models. Suitable technologies will be promoted to the community, allowing residents to enjoy convenient dry eye diagnosis and treatment services at their doorstep. Executive Dean and Party Secretary Gao Wei stated that this is also one of the livelihood service measures recently launched by the hospital around high-quality development and meeting the needs of the people. It is reported that dry eye syndrome is a chronic ocular surface disease caused by multiple factors. The instability of the tear film or imbalance of the ocular surface microenvironment caused by abnormal quality, quantity, and dynamics of tears can be accompanied by ocular surface inflammatory reactions, tissue damage, and nerve abnormalities, resulting in various discomforts in the eyes

The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice
The Ninth Hospital has taken the lead in formulating the world's first consensus on core indicators for clinical evaluation of dental implants, which has been officially published in clinical practice

The International Dental Implant Consensus Report, jointly written by the Ninth People's Hospital affiliated with Shanghai Jiao Tong University School of Medicine and renowned universities in the field of dentistry such as Harvard University, University of Zurich, University of Gothenburg, Columbia University, and University of Frankfurt, has recently been jointly published in top journals in the field of dentistry, including Clinical Periodontology and Clinical Dental Implant Research. This consensus has for the first time established an internationally unified core set of indicators for evaluating the clinical effectiveness of dental implants, covering the five key areas of the field of dental implants. It is of milestone significance for carrying out standardized clinical diagnosis, treatment, and research on dental implants. The core evaluation indicators determined by this consensus will become an important benchmark for scholars in the field of dental implants worldwide to conduct high-quality research. The consensus is composed of 8 top international experts in the field of oral implantation

Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases
Recently, autologous hematopoietic stem cell therapy was completed in Shanghai, and British girls born in the 1990s have suffered from multiple relapses of blood diseases, including stem cells, peripheral blood, and diseases

Recently, Catherine, a British girl born in the 1990s, received autologous peripheral blood hematopoietic stem cell transfusion at the Cancer Center of Shanghai Jiahui International Hospital, and was successfully discharged from the warehouse. She is now on her way back to China after being discharged from the hospital. She is also the first patient at Shanghai Jiahui International Hospital to complete relevant treatments. In 2019, Catherine was diagnosed with Hodgkin's lymphoma in the UK, and after treatment, the disease completely improved. During her work and life in China in 2021, she went to seek medical attention due to multiple enlarged lymph nodes. Pathological biopsy confirmed a recurrence of Hodgkin's lymphoma, and through combined targeted drug treatment, her condition was temporarily under control. Last year in the second half of the year, when the disease recurred, the girl began to use immunotherapy combined with targeted drugs for treatment. Expert evaluation suggests that for young patients with hematological tumors, the risk of recurrence is high and treatment difficulty is increasing in the future. Autologous hematopoietic stem cell therapy is recommended